Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00301028 · FLOW

Participant flow

Cetuximab, Carboplatin, and Paclitaxel Followed by Radiation Therapy, With or Without Cisplatin, in Treating Patients With Metastatic Head and Neck Cancer · Source last updated 2013-04-05

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups
  1. description
    Cetuximab beginning weekly dose 400 mg/m\^2 intravenous (IV), and 250 mg/m\^2 weeks 2-6; Weekly Carboplatin Area Under the Curve (AUC) 2 and Paclitaxel 135 mg/m\^2 for 6 courses.
    id
    FG000
    title
    Cetuximab + Carboplatin/Paclitaxel
periods
  1. milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        47
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        47
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        0
      type
      NOT COMPLETED
    title
    Overall Study
pre Assignment Details
Of the forty-eight (48) participants registered, forty-seven (47) were eligible to participate in this trial
recruitment Details
Recruitment Period: January 31, 2005 to September 16, 2011
Complete source fields
groups
  1. description
    Cetuximab beginning weekly dose 400 mg/m\^2 intravenous (IV), and 250 mg/m\^2 weeks 2-6; Weekly Carboplatin Area Under the Curve (AUC) 2 and Paclitaxel 135 mg/m\^2 for 6 courses.
    id
    FG000
    title
    Cetuximab + Carboplatin/Paclitaxel
periods
  1. milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        47
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        47
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        0
      type
      NOT COMPLETED
    title
    Overall Study
pre Assignment Details
Of the forty-eight (48) participants registered, forty-seven (47) were eligible to participate in this trial
recruitment Details
Recruitment Period: January 31, 2005 to September 16, 2011

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice